CKD-314

· Chong Kun Dang Pharmaceutical

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CKD-314, covering 2021-08-02 to 2021-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia [Phase 2]

See pricing